Luc Thomas
Impact in
- Oncology top 0.05%
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- Health Informatics top 0.2%
- Artificial Intelligence in Healthcare and Education
Papers in
- Oncology 199
- Cutaneous Melanoma Detection and Management 177
- Cancer Immunotherapy and Biomarkers 28
- Dermatology 80
- Cancer and Skin Lesions 26
- Cutaneous lymphoproliferative disorders research 17
- Medicine and Dermatology Studies History 16
- Co-authors
- Stéphane Dalle (140 shared papers)B. Balme (114 shared papers)Jean‐Jacques Grob (12 shared papers)Sébastien Debarbieux (48 shared papers)Alice Phan (22 shared papers)Claus Garbe (10 shared papers)Sandra Ronger-Savle (18 shared papers)Michele Maio (8 shared papers)
- Journals
- British Journal of Dermatology (48 papers)Dermatology (35 papers)Journal of the European Academy of Dermatology and Venereology (32 papers)Journal of the American Academy of Dermatology (16 papers)JAMA Dermatology (16 papers)
- Partner nations
- FranceItalyUnited States
In The Last Decade
Luc Thomas
376 papers receiving 25.9k citations
Luc Thomas's Hit Papers
Peers
Comparison fields: 5 of 166
- Oncology 14.9k
- Health Informatics 517
- Dermatology 1.4k
- Molecular Biology 4.6k
- Immunology 1.2k
Countries citing papers authored by Luc Thomas
This map shows the geographic impact of Luc Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luc Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luc Thomas more than expected).
Fields of papers citing papers by Luc Thomas
This network shows the impact of papers produced by Luc Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luc Thomas. The network helps show where Luc Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Luc Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 407 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma Hit paper breakdown → | 2011 | 3745 |
| 2 | Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial Hit paper breakdown → | 2015 | 2303 |
| 3 | Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma Hit paper breakdown → | 2014 | 1710 |
| 4 | Man against machine: diagnostic performance of a deep learning convolutional neural network for dermoscopic melanoma recognition in comparison to 58 dermatologists Hit paper breakdown → | 2018 | 1146 |
| 5 | Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy Hit paper breakdown → | 2016 | 1101 |
| 6 | Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study Hit paper breakdown → | 2009 | 1036 |
| 7 | Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial Hit paper breakdown → | 2016 | 829 |
| 8 | Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial Hit paper breakdown → | 2017 | 604 |
| 9 | 2011 | 429 | |
| 10 | 2017 | 423 | |
| 11 | 2015 | 407 | |
| 12 | 2019 | 405 | |
| 13 | 2017 | 395 | |
| 14 | 2009 | 302 | |
| 15 | 1992 | 293 | |
| 16 | 2019 | 264 | |
| 17 | 2018 | 255 | |
| 18 | 2017 | 248 | |
| 19 | 2017 | 232 | |
| 20 | 2002 | 229 |
About Luc Thomas
Luc Thomas is a scholar working on Oncology, Dermatology, Epidemiology, Pathology and Forensic Medicine and Molecular Biology, having authored 407 papers that have together received 26.9k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (177 papers), Melanoma and MAPK Pathways (44 papers), Cancer Immunotherapy and Biomarkers (28 papers), Cancer and Skin Lesions (26 papers), Nail Diseases and Treatments (26 papers), Nonmelanoma Skin Cancer Studies (22 papers), Cutaneous lymphoproliferative disorders research (17 papers) and Medicine and Dermatology Studies History (16 papers). The work is most often cited by research in Oncology (14.9k citations), Health Informatics (517 citations), Dermatology (1.4k citations), Molecular Biology (4.6k citations) and Immunology (1.2k citations). Luc Thomas has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Stéphane Dalle, B. Balme, Jean‐Jacques Grob, Sébastien Debarbieux, Alice Phan, Claus Garbe, Sandra Ronger-Savle, Michele Maio, Brigitte Dréno and Paolo A. Ascierto. Their work appears in journals such as British Journal of Dermatology, Dermatology, Journal of the European Academy of Dermatology and Venereology, Journal of the American Academy of Dermatology and JAMA Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.